These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1748 related items for PubMed ID: 18544359

  • 1. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR.
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [Abstract] [Full Text] [Related]

  • 2. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, Ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ.
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [Abstract] [Full Text] [Related]

  • 3. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.
    Hagen JA, Peters JH, DeMeester TR.
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):850-8; discussion 858-9. PubMed ID: 8231207
    [Abstract] [Full Text] [Related]

  • 4. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Chang KH, McAnena OJ.
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):253; author reply 253-4. PubMed ID: 19154939
    [No Abstract] [Full Text] [Related]

  • 5. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C, Taillier G, Van Seuningen I, Triboulet JP.
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [Abstract] [Full Text] [Related]

  • 6. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus.
    Johansson J, DeMeester TR, Hagen JA, DeMeester SR, Peters JH, Oberg S, Bremner CG.
    Arch Surg; 2004 Jun; 139(6):627-31; discussion 631-3. PubMed ID: 15197089
    [Abstract] [Full Text] [Related]

  • 7. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia.
    Peyre CG, DeMeester SR, Rizzetto C, Bansal N, Tang AL, Ayazi S, Leers JM, Lipham JC, Hagen JA, DeMeester TR.
    Ann Surg; 2007 Oct; 246(4):665-71; discussion 671-4. PubMed ID: 17893503
    [Abstract] [Full Text] [Related]

  • 8. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 9. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E, Dar R, Rodrigues GB, Stitt L, Videtic GM, Truong P, Tomiak A, Ash R, Brecevic E, Inculet R, Malthaner R, Vincent M, Craig I, Kocha W, Lefcoe M.
    Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
    [Abstract] [Full Text] [Related]

  • 10. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
    Leers JM, Ayazi S, Hagen JA, Terterov S, Klipfel N, Oezcelik A, Abate E, Lipham JC, DeMeester SR, Banki F, DeMeester TR.
    J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
    [Abstract] [Full Text] [Related]

  • 11. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD, Gaur P, Force SD, Staley CA, Mansour KA, Miller JI, Miller DL.
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [Abstract] [Full Text] [Related]

  • 12. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC, Port JL, Paul S, Stiles BM, Altorki NK.
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [Abstract] [Full Text] [Related]

  • 13. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
    Blewett CJ, Miller JD, Ramlawi B, Young JE, BennettWF, Urschel JD.
    J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
    [Abstract] [Full Text] [Related]

  • 14. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus.
    Oh DS, Hagen JA, Chandrasoma PT, Dunst CM, Demeester SR, Alavi M, Bremner CG, Lipham J, Rizzetto C, Cote R, Demeester TR.
    J Am Coll Surg; 2006 Aug; 203(2):152-61. PubMed ID: 16864027
    [Abstract] [Full Text] [Related]

  • 15. En-bloc esophagectomy for esophageal cancer.
    Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Tabara H, Nagasue N.
    Am J Surg; 2004 Sep; 188(3):254-60. PubMed ID: 15450830
    [Abstract] [Full Text] [Related]

  • 16. Ten-year survival of esophageal cancer after an en-bloc esophagectomy.
    Oezcelik A, Kaiser GM, Niebel W, Sleyman C, Treckmann JW, Sotiropoulos GC, Reinhardt R, Trarbach T, Malamutmann E, Paul A.
    J Surg Oncol; 2012 Mar; 105(3):284-7. PubMed ID: 21953648
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK, Sutton C, Rotimi O, Dexter S, Sue-Ling H, Sarela AI.
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [Abstract] [Full Text] [Related]

  • 18. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients.
    Portale G, Hagen JA, Peters JH, Chan LS, DeMeester SR, Gandamihardja TA, DeMeester TR.
    J Am Coll Surg; 2006 Apr; 202(4):588-96; discussion 596-8. PubMed ID: 16571425
    [Abstract] [Full Text] [Related]

  • 19. Transhiatal esophagectomy for distal and cardia cancers: implications of a positive gastric margin.
    DiMusto PD, Orringer MB.
    Ann Thorac Surg; 2007 Jun; 83(6):1993-8; discussion 1998-9. PubMed ID: 17532385
    [Abstract] [Full Text] [Related]

  • 20. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM, Mirza F, Coppolino A, Port JL, Lee PC, Paul S, Altorki NK.
    Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 88.